Vergoeding 2017-2021 voor ATC-subgroep B01AC : Trombocytenaggregatieremmers excl heparine
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| B01AC04 Clopidogrel (Plavix ®) | 3.732.600 | 4.491.900 | 5.976.800 | 6.794.000 | 7.194.300 |
| B01AC06 Acetylsalicylzuur (Aspirine protect ®) | 9.068.300 | 8.002.000 | 6.736.500 | 6.322.000 | 7.185.400 |
| B01AC07 Dipyridamol (Persantin ®) | 9.152.600 | 8.609.200 | 2.897.900 | 2.613.300 | 2.215.200 |
| B01AC08 Carbasalaatcalcium (Ascal cardio neuro ®) | 4.673.500 | 4.162.900 | 3.530.500 | 3.275.700 | 2.949.000 |
| B01AC09 Epoprostenol (Flolan ®) | 845.270 | 776.470 | 1.148.500 | 1.107.600 | 1.060.700 |
| B01AC11 Iloprost (Ventavis ®) | 655.160 | 338.430 | 192.510 | 220.150 | 217.590 |
| B01AC21 Treprostinil (Remodulin ®) | 4.203.400 | 4.996.400 | 4.447.500 | 3.723.500 | 3.216.900 |
| B01AC22 Prasugrel (Efient ®) | 1.520.500 | 1.444.300 | 1.260.000 | 1.167.100 | 1.181.100 |
| B01AC24 Ticagrelor (Brilique ®) | 16.633.600 | 16.607.100 | 17.245.000 | 16.772.500 | 15.660.300 |
| B01AC27 Selexipag (Uptravi ®) | 2.469.700 | 4.102.000 | 7.971.700 | 8.376.800 | 8.487.200 |
| B01AC30 Combinatiepreparaten | 1.557.500 | 1.252.800 | 1.132.200 | 29.375 | 6.374 |
| Totaal | 54.512.130 | 54.783.500 | 52.539.110 | 50.402.025 | 49.374.064 |